Small Business Stock Gain Exclusion Receives 2014 Extension
It’s not like the government to bring everyone some well-needed Christmas cheer, but the new tax bill that lawmakers were finally able to pass brought some good news for many investors before the year ends. It’s unfortunate that it took the entire year to get it done, but at least the tax provisions that did get extended will be good for the entire tax year of 2014.
One important extension affected the small business stock gain exclusion. The new act signed this last week extended the 100% exclusion for small business stock acquired in 2014. That means if the individual shareholder holds the qualified small business stock for five years, they can exclude up to the first $10 million of capital gain for Federal purposes, instead of having to hold it for 10 years before doing so. The exclusion even applies for both regular tax and the Alternative Minimum Tax (ATM).
It’s important to note that for now this extension is only good for the year 2014 and does not apply to next year’s taxes, however, Congress could vote to extend it again next year, as well. If you would like to learn about the Sec. 1202 Small Business Stock Gain, and how it works, then just click here for a detailed explanation. And feel free to contact us at GROCO with any of your tax questions by clicking here.
Armin Tahmasbi | Encapsulate
I’m a young entrepreneur and a Ph.D. candidate in Biomedical Engineering program at the University of Connecticut, working on “Drug Delivery Systems, Self-Assembled Nanoparticles & Microfluidic Devices”, in Storrs, CT, US. I’m working in Self-Assembled Functional Nanomaterials Laboratory, under the supervision of Prof. Mu-Ping Nieh on “Drug Delivery Systems for cancer therapy”. We’re developing a universal platform for encapsulating and smart delivery of a wide range of drug molecules and
Spencer Jones | Lineus Medical
Spencer worked for 3 years in direct patient care as a Certified Nursing Assistant, Licensed Practical Nurse, and as a Registered Nurse. Frustrated with the inefficiencies plaguing the healthcare system, he was determined to play a role in improving the delivery of healthcare. In 2014, Spencer won the annual ARK Challenge, an Arkansas based business accelerator. The product he developed was a dual lumen peripheral IV called the BVAD, which focuses on painless and uncontaminated blood draws.
Adeel Malik | CEO of Clearstep
While studying finance and neurobiology in undergrad, Adeel spent his time doing neuro-immunology research at the Johns Hopkins Hospital, contributing to several academic publications. After undergrad, Adeel was a strategy & analytics consultant with Accenture for several years where he worked with some of the largest institutions in healthcare across pharma, health tech, health systems, and retail clinics. Adeel’s skills in healthcare analytics, operations, sales, and his breadth of experience
Yael Katz | How BrainCheck is Democratizing Cognitive Health
Dr. Yael Katz is the co founder and CEO of Braincheck, a healthcare technology company focused on making cognitive health assessments more accessible. Prior to co founding Braincheck, Yael was VP of ecommerce at JW Player and a post doctoral research fellows at Princeton University. She received a Ph.D in in Biological Sciences focusing on Computational and Experimental Neuroscience from Northwestern University.Alan What brought you to co founding Braincheck? Yael If a person has a concern that